Significant Accounting Policies |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Accounting Policies |
2. Significant Accounting Policies
Basis of Presentation
The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto of the Company contained elsewhere herein.
In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements of the Company for the years ended December 31, 2020 and 2019 as reported in the Company’s Form 10-K have been omitted.
As of June 30, 2021, the Company has common stock equivalents related to warrants outstanding to acquire shares of the Company’s common stock. As of June 30, 2020, the Company had warrants.
As of June 30, 2021, the Company has common stock equivalents related to convertible preferred stock issued and outstanding. As of June 30, 2020, the Company had common stock equivalents related to shares of the Company’s common stock issuable upon conversion of the Company’s Series A Preferred Stock, shares of the Company’s common stock issuable upon conversion of the Company’s Series B Preferred Stock, shares of the Company’s common stock issuable upon conversion of the Company’s Series C Preferred Stock, and shares of the Company’s common stock issuable upon conversion of the Company’s Series D Preferred Stock issued and outstanding.
|